Bing

SEARCH HISTORY

Cyclacel Pharmaceuticals (NASDAQ:CYCC) is one of today's worst performing penny stocks, down 8.7% to $0.72 on 1.1x average daily volume. Cyclacel Pharmaceuticals has traded 433,000 shares thus far today, vs. average volume of 412,000 shares per day.
Financial News Network Online · ByAdrienne Chilton · 5/28/2015
Could the long slump for Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) finally be over? Patient shareholders of CYCC have certainly been tested, with the stock falling from early 2010 highs around $3.00 to a multi-year low of $0.36 in October. But ...
Smallcap Network · ByJames E. Brumley · 3/28/2012
Well, as we know there are two types of person in the stock market one is trader and another ... We told our members in facebook private group to buy Cyclacel Pharmaceuticals Inc(NASDAQ:CYCC) this morning at $1.44. Now look at the price of the stock ...
Market News Call · 2/27/2015
More from Bing News
New York, NY – NISMAGAZINE – 03/02/2015. This article discusses three companies: Cyclacel Pharmaceuticals Inc(NASDAQ:CYCC), Rovi Corporation(NASDAQ:ROVI) and Sophiris Bio Inc(NASDAQ:SPHS) Cyclacel Pharmaceuticals Inc(NASDAQ …
Nautilus Investment Strategies Magazine · 3/2/2015
Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) (Nasdaq: CYCCP) (Cyclacel or the Company), today announced the pricing of the underwritten offering of 6,666,667 shares of its common stock at a price to the public of $3.00 per share. Cyclacel has …
StreetInsider · 5/16/2013
Cyclacel Pharmaceuticals (NASDAQ:CYCC) traded up 2.7406% during mid-day trading on Tuesday, hitting $0.7685. 155,183 shares of the company’s stock traded hands. Cyclacel Pharmaceuticals has a 52 week low of $0.5100 and a 52 week high of $3.
wkrb13.com · 5/12/2015
Shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC) traded up 2.7406% during mid-day trading on Tuesday, hitting $0.7685. 155,183 shares of the company’s stock traded hands. Cyclacel Pharmaceuticals has a one year low of $0.5100 and a one year …
Ticker Report · 5/12/2015
5 Best Stocks Under $5 is a feature intended to pinpoint smaller stocks ... Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) is a small biopharmaceutical company that is working on antibody engineering to treat cancer, leukemia, and other serious diseases.
Investor Place · 2/27/2015
Cyclacel Pharmaceuticals, Inc. (CYCC) is one of Tuesday’s notable stocks in decline, down 64% to $1.03. The plunge comes after the company announced enrollment of 486 patients, continuation to final analysis and recommendations of the independent …
Wall Street Pit · 12/16/2014
Cyclacel (NASDAQ: CYCC ) is getting in gear to expand its capital base. The company is floating a new issue of common stock in an underwritten public offering. Just under 6.67 million shares of the firm will be sold at a price of $3.00 apiece. Additionally ...
The Motley Fool · ByEric Volkman · 5/16/2013